Os04g0119400 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
Os04g0119400 antibody; LOC_Os04g02900 antibody; OsJ_13591 antibody; OSJNBa0020P07.11 antibody; Pyruvate dehydrogenase E1 component subunit alpha-3 antibody; chloroplastic antibody; EC 1.2.4.1 antibody
Target Names
Os04g0119400
Uniprot No.

Target Background

Function
The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO2. It comprises multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2), and lipoamide dehydrogenase (E3).
Database Links
Subcellular Location
Plastid, chloroplast.

Q&A

What is the Os04g0119400 antibody, and what are its primary applications in research?

The Os04g0119400 antibody is a specialized reagent designed to target the Os04g0119400 protein, which is encoded by the corresponding gene in Oryza sativa (rice). It is commonly used in plant biology research, particularly for studies investigating protein expression, localization, and functional roles within cellular processes. This antibody is applicable in techniques such as Western blotting (WB), enzyme-linked immunosorbent assay (ELISA), and immunohistochemistry (IHC) .

Its primary applications include:

  • Protein detection: Identifying the presence and abundance of the Os04g0119400 protein under various experimental conditions.

  • Functional studies: Elucidating the role of this protein in physiological or stress-response pathways.

  • Localization: Mapping the spatial distribution of the protein within plant tissues or cellular compartments.

Methodologically, researchers must validate the antibody's specificity through controls such as pre-absorption assays or knockout models to ensure reliable results .

How can researchers design experiments to validate the specificity of the Os04g0119400 antibody?

Antibody validation is critical for ensuring that experimental results accurately reflect the presence and behavior of the target protein rather than nonspecific binding. The following methodological approaches are recommended:

  • Western blot analysis: Run samples containing the target protein alongside negative controls (e.g., samples from knockout plants lacking Os04g0119400). Specificity is confirmed if only the expected band corresponding to the molecular weight of Os04g0119400 appears .

  • Immunoprecipitation (IP): Use the antibody to pull down its target from a complex mixture. Subsequent mass spectrometry can confirm that the pulled-down protein matches Os04g0119400.

  • Pre-absorption assays: Incubate the antibody with an excess of purified Os04g0119400 protein prior to use in experiments. A reduction or disappearance of signal indicates specificity.

  • Genetic validation: Employ RNA interference (RNAi) or CRISPR-Cas9 techniques to knock down or knock out Os04g0119400 expression in rice plants. The absence of signal in these models further confirms specificity.

These validation steps ensure reproducibility and reliability in scientific publications .

What challenges might arise when using the Os04g0119400 antibody in Western blotting experiments?

Western blotting is a widely used technique for protein detection, but researchers may encounter challenges specific to antibodies like Os04g0119400:

  • Nonspecific binding: This occurs when the antibody binds to proteins other than its intended target. To mitigate this, include stringent washing steps and use blocking agents such as bovine serum albumin (BSA).

  • Low sensitivity: If signals are weak, optimize conditions by adjusting antibody concentrations or using enhanced chemiluminescence (ECL) substrates.

  • Cross-reactivity: The Os04g0119400 antibody may recognize homologous proteins in other species or isoforms within rice. Employing peptide competition assays can help identify cross-reactivity.

  • Sample preparation issues: Degradation or incomplete extraction of proteins may lead to poor results. Use protease inhibitors during sample preparation and ensure proper denaturation conditions.

A well-designed protocol addressing these challenges ensures robust data generation .

How does post-translational modification impact detection of Os04g0119400 using its antibody?

Post-translational modifications (PTMs) such as phosphorylation, glycosylation, or ubiquitination can alter the antigenic properties of proteins, potentially affecting antibody binding. For Os04g0119400:

  • Phosphorylation: PTMs might mask epitopes recognized by the antibody. Researchers can use phosphatase treatments to remove modifications and assess their impact on detection.

  • Glycosylation: Glycosylated forms may migrate differently on SDS-PAGE gels, complicating interpretation. Enzymatic deglycosylation can clarify results.

  • Ubiquitination: This modification may lead to higher molecular weight bands due to conjugated ubiquitin chains.

To study PTMs directly, researchers should employ modification-specific antibodies alongside Os04g0119400 antibodies or use mass spectrometry for precise characterization .

What experimental controls are essential when using antibodies in immunohistochemistry?

Immunohistochemistry (IHC) requires rigorous controls to validate staining patterns and avoid misinterpretation:

  • Negative controls: Include tissue sections incubated without primary antibodies or with irrelevant antibodies to identify nonspecific staining.

  • Positive controls: Use tissues known to express Os04g0119400 abundantly.

  • Blocking controls: Pre-incubate antibodies with an excess of purified antigen to confirm specificity.

  • Secondary antibody controls: Ensure secondary antibodies do not produce background signals by testing them alone.

These controls help differentiate genuine signal from artifacts .

How can researchers address data contradictions when studying Os04g0119400 expression under stress conditions?

Contradictions in data regarding stress-induced expression of Os04g0119400 often arise due to differences in experimental design or biological variability. To resolve these:

  • Standardize experimental conditions: Ensure consistent stress application methods (e.g., drought simulation) across replicates.

  • Use quantitative methods: Employ quantitative PCR (qPCR) or ELISA for precise measurement of expression levels.

  • Replicate experiments across genotypes: Assess whether genetic background influences results.

  • Integrate omics approaches: Combine transcriptomics and proteomics data for comprehensive insights into stress responses.

Critical evaluation of methodology and cross-validation with independent datasets enhance reliability .

What databases provide sequence information relevant to Os04g0119400 antibodies?

Several databases offer curated sequence information that aids researchers working with antibodies:

  • Observed Antibody Space (OAS): Provides annotated sequences for heavy and light chains, facilitating comparisons between similar antibodies .

  • ImmuneAccess and PIRD: Offer large collections of annotated B-cell receptor sequences useful for understanding immune responses .

  • MiAIRR-compliant repositories: These repositories ensure standardized data processing pipelines for reproducible research.

Researchers can leverage these resources for designing new experiments or validating existing findings .

How does conjugation affect the functionality of Os04g0119400 antibodies?

Conjugation involves attaching functional moieties such as fluorophores or enzymes to antibodies for specific applications like flow cytometry or ELISA:

  • Impact on binding affinity: Conjugation may sterically hinder binding sites, reducing affinity.

  • Optimization strategies: Use spacers between the antibody and conjugate to minimize interference.

  • Choice of conjugate: Select conjugates based on experimental requirements (e.g., HRP for chemiluminescence).

Researchers must validate conjugated antibodies separately from unconjugated versions .

What are best practices for publishing data generated using Os04g0119400 antibodies?

Publishing meaningful data requires adherence to rigorous standards:

  • Validation transparency: Include detailed methods validating antibody specificity.

  • Reproducibility emphasis: Provide raw data files alongside processed figures.

  • Methodological clarity: Clearly describe experimental protocols, including controls used.

Compliance with guidelines like ARRIVE ensures high-quality publications that advance scientific understanding .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.